GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
0.4112
-0.0052 (-1.25%)
Mar 11, 2026, 10:59 AM EDT - Market open
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $12.97 million as of March 11, 2026. Its market cap has increased by 188.33% in one year.
Market Cap
12.97M
Enterprise Value
6.33M
1-Year Change
188.33%
Ranking
Category
Stock Price
$0.41
Market Cap Chart
Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $12.97M, a decrease of -84.41%. That is a compound annual growth rate of -20.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 13.10M | 57.83% |
| Dec 31, 2025 | 8.30M | 22.06% |
| Dec 31, 2024 | 6.80M | -35.85% |
| Dec 29, 2023 | 10.60M | -63.19% |
| Dec 30, 2022 | 28.80M | -69.13% |
| Dec 31, 2021 | 93.30M | 181.02% |
| Dec 31, 2020 | 33.20M | 503.64% |
| Dec 31, 2019 | 5.50M | -83.13% |
| Dec 31, 2018 | 32.60M | -60.82% |
| Mar 27, 2018 | 83.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IN8bio | 16.80M |
| Serina Therapeutics | 16.50M |
| Hoth Therapeutics | 15.41M |
| Quoin Pharmaceuticals | 14.60M |
| Cocrystal Pharma | 13.92M |
| Curis | 13.56M |
| Quantum BioPharma | 13.38M |
| Jupiter Neurosciences | 13.32M |